Literature DB >> 24563617

Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.

Maroun Karam1, Morgan Thenoz1, Valérie Capraro1, Jean-Philippe Robin1, Christiane Pinatel1, Agnès Lancon1, Perrine Galia1, David Sibon2, Xavier Thomas3, Sophie Ducastelle-Lepretre3, Franck Nicolini3, Mohamed El-Hamri3, Youcef Chelghoun3, Eric Wattel4, Franck Mortreux1.   

Abstract

Although numerous factors have been found to modulate hTERT transcription, the mechanism of its repression in certain leukemias remains unknown. We show here that DEK represses hTERT transcription through its enrichment on the hTERT promoter in cells from chronic and acute myeloid leukemias, chronic lymphocytic leukemia, but not acute lymphocytic leukemias where hTERT is overexpressed. We isolated DEK from the hTERT promoter incubated with nuclear extracts derived from fresh acute myelogenous leukemia (AML) cells and from cells expressing Tax, an hTERT repressor encoded by the human T cell leukemia virus type 1. In addition to the recruitment of DEK, the displacement of two potent known hTERT transactivators from the hTERT promoter characterized both AML cells and Tax-expressing cells. Reporter and chromatin immunoprecipitation assays permitted to map the region that supports the repressive effect of DEK on hTERT transcription, which was proportionate to the level of DEK-promoter association but not with the level of DEK expression. Besides hTERT repression, this context of chromatin redistribution of DEK was found to govern about 40% of overall transcriptional modifications, including those of cancer-prone genes. In conclusion, DEK emerges as an hTERT repressor shared by various leukemia subtypes and seems involved in the deregulation of numerous genes associated with leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24563617      PMCID: PMC3927101          DOI: 10.1593/neo.131658

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  38 in total

1.  The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils.

Authors:  Tanja Waldmann; Carmen Eckerich; Martina Baack; Claudia Gruss
Journal:  J Biol Chem       Date:  2002-05-07       Impact factor: 5.157

2.  Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.

Authors:  Mónica Campillos; Miguel Angel García; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

3.  Structure-specific binding of the proto-oncogene protein DEK to DNA.

Authors:  Tanja Waldmann; Martina Baack; Nicole Richter; Claudia Gruss
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

4.  Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--Excel-based tool using pair-wise correlations.

Authors:  Michael W Pfaffl; Ales Tichopad; Christian Prgomet; Tanja P Neuvians
Journal:  Biotechnol Lett       Date:  2004-03       Impact factor: 2.461

5.  Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.

Authors:  Ferdinand Kappes; Catalina Damoc; Rolf Knippers; Michael Przybylski; Lorenzo A Pinna; Claudia Gruss
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

6.  Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells.

Authors:  Uma Sinha-Datta; Izumi Horikawa; Eriko Michishita; Abhik Datta; Janitzia C Sigler-Nicot; Megan Brown; Mirdad Kazanji; J Carl Barrett; Christophe Nicot
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

7.  The leucine zipper of c-Myc is required for full inhibition of erythroleukemia differentiation.

Authors:  M J Smith; D C Charron-Prochownik; E V Prochownik
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

8.  p300/CBP-associated factor drives DEK into interchromatin granule clusters.

Authors:  Joanne Cleary; Kajal V Sitwala; Michael S Khodadoust; Roland P S Kwok; Nirit Mor-Vaknin; Marek Cebrat; Philip A Cole; David M Markovitz
Journal:  J Biol Chem       Date:  2005-06-28       Impact factor: 5.157

9.  Multiple tumor suppressor pathways negatively regulate telomerase.

Authors:  Shiaw Yih Lin; Stephen J Elledge
Journal:  Cell       Date:  2003-06-27       Impact factor: 41.582

10.  Inactivation of hTERT transcription by Tax.

Authors:  Anne-Sophie Gabet; Franck Mortreux; Pierre Charneau; Patrice Riou; Madeleine Duc-Dodon; Yalin Wu; Kuan-Teh Jeang; Eric Wattel
Journal:  Oncogene       Date:  2003-06-12       Impact factor: 9.867

View more
  7 in total

1.  DEK over-expression promotes mitotic defects and micronucleus formation.

Authors:  Marie C Matrka; Robert F Hennigan; Ferdinand Kappes; Monica L DeLay; Paul F Lambert; Bruce J Aronow; Susanne I Wells
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

Review 2.  Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer.

Authors:  Nicholas A Pease; Trisha Wise-Draper; Lisa Privette Vinnedge
Journal:  J Oncol       Date:  2015-09-06       Impact factor: 4.375

3.  Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.

Authors:  Lijuan Lin; Junjie Piao; Yibing Ma; Tiefeng Jin; Chengshi Quan; Jienan Kong; Yulin Li; Zhenhua Lin
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

4.  The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.

Authors:  L M Privette Vinnedge; N M Benight; P K Wagh; N A Pease; M A Nashu; J Serrano-Lopez; A K Adams; J A Cancelas; S E Waltz; S I Wells
Journal:  Oncogene       Date:  2014-06-23       Impact factor: 9.867

5.  Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.

Authors:  Marie C Matrka; Katherine A Cimperman; Sarah R Haas; Geraldine Guasch; Lisa A Ehrman; Ronald R Waclaw; Kakajan Komurov; Adam Lane; Kathryn A Wikenheiser-Brokamp; Susanne I Wells
Journal:  PLoS Genet       Date:  2018-03-14       Impact factor: 5.917

6.  DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma.

Authors:  Huochun Yi; Hongbing Duan; Wensheng Shi; Zhengjin Liu; Yali Liu
Journal:  Arch Med Sci       Date:  2019-04-05       Impact factor: 3.318

Review 7.  Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.

Authors:  Muhammad Khairul Ramlee; Jing Wang; Wei Xun Toh; Shang Li
Journal:  Genes (Basel)       Date:  2016-08-18       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.